Allied Market Research
Upcoming Allied Market Research
Neoantigen Market

Neoantigen Market by Type (Nucleic Acid, Dendritic Acid, Tumor Cell, and Synthetic Long Peptide) , Product (Personalized Neo-Antigen Vaccine and Off-The Shell Neoantigen Vaccine), Cell (Autologous and Allogeneic), Treatment (Combination Therapy and Mono Therapy), Therapeutic Specialty (Gastrointestinal Cancer, Lung Cancer, Solid Tumor, Urinary Systems Cancers, Melanoma, Head & Neck Cancer, and Others), Technology (Whole Genome Sequencing, RNA Sequencing, and HLA Typing), Delivery Mechanism (Gene Gun, Electroporation, Liposomes, Virosomes, and Others), and Route of Administration (Intravenous, Intramuscular, Transdermal, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Nov 2021 | 34 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neoantigen Market

Request Now !

Neoantigen is a protein that forms on the cancerous cells as a result on mutations in the tumorous DNA. They are thus used in development on vaccines and immunotherapies against cancer cells. Neoantigens are recognized in the body by neoantigen-specific T cell receptors (TCRs). Neoantigen-based vaccines and target therapies have shown promising results in various clinical trials, owing to the fact that they can be recognized as non-self/foreign and germline by the host’s immune system. Neoantigens find huge significance in cancer immunoediting. It is a technique used to establish dual roles of immune system with respect to tumor growth. Several studies have postulated the fact that neoantigen immunotherapy can in fact aid in controlling tumor outgrowth, facilitate cellular transformation and share immunogenicity of tumors. Furthermore, neoantigens can be divided into personalized neoantigens and shared neoantigens. Shared neoantigens are not present specifically in regards to individualized genome while personalized neontigens are targeted on specific individuals. Prediction on the number of neoantigens present involves a well thought validated algorithms to select more reliable neoepitopes. The procedure for development of neoantigen cancer vaccine involves obtaining tumorous tissues from the patient and subsequently identifying mutant genes of the tumor. Post this, RNA/DNA sequent test is carried out to select appropriate mutated antigens. Finally, these mutated antigens are designed into suitable vaccines.

Market Scope and Structure Analysis

Report Metric


 Market Size Available for Years


 Base Year Considered


 Forecast Period


 Forecast Unit

 Value (USD)

 Segments Covered

Treatment, Therapeutic Specialty, Technology, End User, and Region

 Regions Covered

North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Achilles Therapeutics plc, Advaxis, Inc., Frame Cancer Therapeutics, Genocea, Gradalis, Inc., Gritstone Oncology, Immunicum AB, Medigene AG, Ziopharm Oncology, Inc., Moderna, Inc., Merck & Co. Inc.


COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global neoantigens market.

Top Impacting Factors

  • Rise in the case of cancer and other chronic diseases coupled with growing demand for advanced therapeutic medications for quick, reliable, and sustainable treatment of cancer is anticipated to drive neoantigens market growth.
  • Recent clinical advancements in biotechnology and growing investments being influx in study of neoantigens and related mechanisms is slated to further boost study of neoantigens market. The trend is more visible in regions with high skilled biotechnological human resource, more economic muscle and internet penetration.
  • Inception of private sector global and regional player who are willing to spend more for design and development of novel medications for eradication or chronic diseases through more clinical trials, frequent product launches, and necessary collaborations & mergers may further fuel the market growth of neoantigens.
  • However, higher cost associated with design and development of personalized cancer medicines may hamper market growth. The factor may largely be visible in regions which lack efficient healthcare infrastructure and fragile government support.
  • Further optimization obstacles and clinical development delays mainly owing to shift of healthcare mechanisms towards battling COVID-19 may further hamper global neoantigen market outlook.

Key Market Trends

  • North America is anticipated to show dominance in neoantigen market owing to rising cases of cancer in the region coupled with growing demand of development of advanced treatment mechanisms.
  • BioNTech S.E. recently developed and launched individualized vaccine against cancer (IVAC) platform that helps in production of customized neoantigen vaccines.
  • Further, Genocea Biosciences developed ATLAS platform for development of neoantigen vaccines. It makes use of an ex-vivo method to treat melanoma, carcinoma, and lung cancers.
  • Agenus Inc. developed AutoSynVax (ASV) neoantigen vaccine to treat solid tumors. It is administered in addition to the adjuvant QS-21 Stimulon.

Key Segments Covered




  • Nucleic Acid
  • Dendritic Acid
  • Tumor Cell
  • Synthetic Long Peptide

 Therapeutic Specialty

  • Gastrointestinal Cancer
  • Lung Cancer
  • Solid Tumor
  • Urinary Systems Cancers
  • Melanoma
  • Head and Neck Cancer
  • Others


  • Personalized Neo-Antigen Vaccine
  •  Off-The Shell Neo-Antigen Vaccine


  • Autologous
  • Allogeneic


  • Combination Therapy
  • Mono Therapy


  • Whole Genome Sequencing
  • RNA Sequencing
  • HLA Typing

 Route of Administration

  • Intravenous
  • Intramuscular
  • Transdermal
  • Others

 Delivery Mechanism

  • Gene Gun
  • Electroporation
  • Liposomes
  • Virosomes
  • Others


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Benefits of the Report

  • This study presents the analytical depiction of the neoantigens industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the neoantigens market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the neoantigens growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Neoantigens Report

  • Which are the leading players active in the neoantigens market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the neoantigens market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is neoantigens?
  • What is the neoantigens market prediction in the future?
  • What are the current trends and predicted trends?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Neoantigen Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers